F. Levischaffer et al., NEDOCROMIL SODIUM AMELIORATES SKIN MANIFESTATIONS IN A MURINE MODEL OF CHRONIC GRAFT-VERSUS-HOST DISEASE, Bone marrow transplantation, 19(8), 1997, pp. 823-828
Dermal fibrosis, loss of cutaneous appendages, and loss of subcutaneou
s fat are the main manifestations of chronic graft-versus-host disease
(cGVHD) in mice, Mast cells (MC) may have a role in cGVHD. To investi
gate this point we have evaluated the effect of a MC stabilizer (nedoc
romil sodium) and a MC activator (compound 48/80) on skin manifestatio
ns in a murine model of cGVHD (B10.D2 --> BALB/c). Mice were treated w
ith nedocromil sodium (5 mg/day) or compound 48/80 (10 mu g/day) from
day -3 until day 15. Nedocromil ameliorated the skin features of cGVHD
while compound 48/80 caused skin changes reminiscent of mild cGVHD in
control mice. In addition nedocromil normalized peritoneal MC numbers
and skin MC numbers and their activation state in the cGVHD mice, On
the other hand compound 48/80 caused a complete disappearance of tolui
dine blue stainable peritoneal MC from cGVHD and control mice and decr
eased skin MC in controls, In summary, MC activation may play a negati
ve role in the skin changes seen in cGVHD while MC stabilization ameli
orates the skin manifestations of cGVHD and therefore may have a thera
peutic benefit.